Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM60A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SH2D3C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2C1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPRD1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSM14A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DLG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP58 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
QSER1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
VAV1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAS2L3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RSBN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ORC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDH6A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFYB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DZIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on